Søgeresultater - Annette Ervin‐Haynes

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma

    Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma af Thomas M. Habermann, Izidore S. Lossos, Glen R. Justice, Julie M. Vose, Peter H. Wiernik, Kyle McBride, Kenton Wride, Annette Ervin‐Haynes, Kenichi Takeshita, Dennis Pietronigro, Jerome B. Zeldis, Joseph M. Tuscano

    Udgivet 2009
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  2. 2
    Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

    Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma af Thomas E. Witzig, Peter H. Wiernik, Timothy D. Moore, Craig B. Reeder, Craig E. Cole, Glen R. Justice, Henry G. Kaplan, Michael Voralia, Dennis Pietronigro, Kenichi Takeshita, Annette Ervin‐Haynes, Jerome B. Zeldis, Julie M. Vose

    Udgivet 2009
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

    Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma af Peter H. Wiernik, Izidore S. Lossos, Joseph M. Tuscano, Glen R. Justice, Julie M. Vose, Craig E. Cole, Wwt Lam, Kyle McBride, Kenton Wride, Dennis Pietronigro, Kenichi Takeshita, Annette Ervin‐Haynes, Jerome B. Zeldis, Thomas M. Habermann

    Udgivet 2008
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma

    Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma af Lotfi Benboubker, Meletios Α. Dimopoulos, Angela Dispenzieri, John Catalano, Andrew R. Belch, Michèle Cavo, Antonio Pinto, Katja Weisel, Heinz Ludwig, Nizar J. Bahlis, Anne Banos, Mourad Tiab, Michel Delforge, Jamie Cavenagh, Catarina Geraldes, Je‐Jung Lee, Christine Chen, Albert Oriol, Javier de la Rubia, Lugui Qiu, Darrell White, Daniel Binder, Kenneth Anderson, Jean-Paul Fermand, Philippe Moreau, Michel Attal, Robert Knight, Guang Chen, Jason Van Oostendorp, Christian Jacques, Annette Ervin‐Haynes, Hervé Avet‐Loiseau, Cyrille Hulin, Thierry Façon

    Udgivet 2014
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

    Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma af Thierry Façon, Meletios Α. Dimopoulos, Angela Dispenzieri, John Catalano, Andrew Belch, Michèle Cavo, Antonio Pinto, Katja Weisel, Heinz Ludwig, Nizar J. Bahlis, Anne Banos, Mourad Tiab, Michel Delforge, Jamie Cavenagh, Catarina Geraldes, Je‐Jung Lee, Christine Chen, Albert Oriol, Javier de la Rubia, Darrell White, Daniel Binder, Jin Lu, Kenneth C. Anderson, Philippe Moreau, Michel Attal, Aurore Perrot, Bertrand Arnulf, Lugui Qiu, Murielle Roussel, Eileen M. Boyle, Salomon Manier, Mohamad Mohty, Hervé Avet‐Loiseau, Xavier Leleu, Annette Ervin‐Haynes, Guang Chen, Vanessa Houck, Lotfi Benboubker, Cyrille Hulin

    Udgivet 2017
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: